ESC Professional Premium Access

Mechanisms of the clinical benefits of SGLT2i in heart failure (EMPEROR-Pooled)

Congress Session

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

3 more presentations in this session

Lifetime prediction and Treatment Benefit in HFrEF (LIFE-HF).

Speaker: Doctor S. Koudstaal (Gouda, NL)

Thumbnail

Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial

Speaker: Doctor B. Ingraham (Rochester, US)

Thumbnail

ENTRIGUE: Pegozafermin for the treatment of severe hypertriglyceridemia.

Speaker: Professor D. Bhatt (Boston, US)

Thumbnail

Access the full session

Late-Breaking Science - Innovations in drug treatment

Speakers: Professor F. Zannad, Doctor S. Koudstaal, Doctor B. Ingraham, Professor D. Bhatt
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk